Biomarin Pharmaceutical (BMRN) Selling, General & Administrative (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Selling, General & Administrative of $395.55 million in Q2 2026, up 70.3% from $232.28 million a year earlier and up 53.1% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a TTM basis, Biomarin Pharmaceutical's Selling, General & Administrative came in at $1.37 billion as of Jun 30, 2026, up 42.8% year-over-year; for FY2025, it came in at $1.15 billion, up 14.3% from FY2024.
- Annual Selling, General & Administrative has increased for 16 straight years, with a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $1.01 billion in FY2024 (+13.1%), $892.41 million in FY2023 (+8.4%), $823.24 million in FY2022 (+8.4%) and $759.38 million in FY2021 (+2.9%).
- Quarterly Selling, General & Administrative has ranged from $183.33 million in Q3 2021 to $446.21 million in Q4 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has increased for four consecutive quarters, with growth averaging 21.1% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 70.3% in Q2 2026, against a decline of 11.7% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $258.29 million (Q1 2026), $446.21 million (Q4 2025) and $268.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn | 395.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 395.55 Mn |
| Mar 31, 2026 | 258.29 Mn |
| Dec 31, 2025 | 446.21 Mn |
| Sep 30, 2025 | 268.42 Mn |
| Jun 30, 2025 | 232.28 Mn |
| Mar 31, 2025 | 206.12 Mn |
| Dec 31, 2024 | 266.61 Mn |
| Sep 30, 2024 | 253.48 Mn |
| Jun 30, 2024 | 263.03 Mn |
| Mar 31, 2024 | 225.91 Mn |
| Dec 31, 2023 | 259.51 Mn |
| Sep 30, 2023 | 215.77 Mn |
| Jun 30, 2023 | 206.10 Mn |
| Mar 31, 2023 | 211.02 Mn |
| Dec 31, 2022 | 214.97 Mn |
| Sep 30, 2022 | 216.82 Mn |
| Jun 30, 2022 | 196.84 Mn |
| Mar 31, 2022 | 194.62 Mn |
| Dec 31, 2021 | 217.56 Mn |
| Sep 30, 2021 | 183.33 Mn |
API Access
Biomarin Pharmaceutical Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();